MAP Pharmaceuticals (MAPP) is focuses on the development and commercialization of inhalation therapies for patients suffering from migraine. This stock is trading up 3.8% at $13.98 in recent trading. Today's Volume: 82,000 Average Volume: 105,917 Volume % Change: 100% >>6 Stocks Hitting New Highs From a technical standpoint, MAPP is quickly approaching its 50-day moving average today at $14.04 on decent volume. Market players should watch for a sustained move and close on high-volume above $14.04 and then $14.72 (its 200-day) to signal that this stock wants to trend much higher. If we get a high-volume move and close above those levels, then look for MAPP to challenge its October high of $16.19 in the near future.